← Browse by Condition
Medical Condition
advanced cancer
Total Trials
9
Recruiting Now
9
Trial Phases
Phase 3, Phase 1, Phase 1, Phase 2
NCT06346197 Phase 3
Recruiting
Combination of Immune Checkpoint in Locally Advanced or Metastatic MSI/dMMR Esogastric Adenocarcinomas
Enrollment
132 pts
Location
France
Sponsor
Centre Leon Berard
NCT05971277
Recruiting
Home And Locally Observed - Tracking (HALO-Trak)
Enrollment
200 pts
Location
United Kingdom
Sponsor
University College, London
NCT06092580 Phase 1
Recruiting
Phase 1 Study of AWT020 in Advanced Cancer
Enrollment
60 pts
Location
Australia
Sponsor
Anwita Biosciences
NCT05076760 Phase 1
Recruiting
MEM-288 Oncolytic Virus Alone and in Combination With Standard of Care Therapy in Advanced Solid Tumors
Enrollment
40 pts
Location
United States
Sponsor
Memgen, Inc.
NCT06081517
Recruiting
Evaluating Disparities in Precision Oncology
Enrollment
10,600 pts
Location
United States
Sponsor
Indiana University
NCT06440005 Phase 1
Recruiting
A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors
Enrollment
80 pts
Location
United States
Sponsor
Angiex, Inc.
NCT07133269
Recruiting
Care Coach-led Integrated Palliative Surgical Oncology and Rehabilitation Care Model for Advanced Cancer Patients
Enrollment
770 pts
Location
Singapore
Sponsor
Singapore General Hospital
NCT05394103 Phase 1, Phase 2
Recruiting
Highly Selective CDK7 Inhibitor Q901 in Selected Advanced Solid Tumors
Enrollment
130 pts
Location
United States, South...
Sponsor
Qurient Co., Ltd.
NCT07009886
Recruiting
Development of an Educational Patient Decision Aid (Treatments in Advanced Cancer - Decision Aid, TA-DA) to Promote Shared Decision Making for Third-line or Beyond Palliative Systemic Therapy
Enrollment
155 pts
Location
United States
Sponsor
M.D. Anderson Cancer Center